ELUCIREM
Drug
GUERBET LLC
Total Payments
$864,951
Transactions
341
Doctors
62
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $678,696 | 184 | 35 |
| 2023 | $8,945 | 6 | 6 |
| 2022 | $177,310 | 151 | 29 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $472,608 | 6 | 54.6% |
| Consulting Fee | $305,922 | 76 | 35.4% |
| Travel and Lodging | $51,207 | 101 | 5.9% |
| Food and Beverage | $23,920 | 154 | 2.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $6,794 | 1 | 0.8% |
| Honoraria | $4,500 | 3 | 0.5% |
Payments by Type
Research
$472,608
6 transactions
General
$392,343
335 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| MR Image Quality and Liver Lesion Detection with Gadopiclenol: Comparison with Gadoxetate Disodium | GUERBET LLC | $146,882 | 0 |
| Noninvasive Diagnosis of Liver Fibrosis with Gadopiclenol DCE-MRI | GUERBET LLC | $133,349 | 0 |
| Gadopiclenol to Increase Accuracy for Local Staging of Challenging Breast Cancers: Invasive Lobular Carcinoma and Ductal Carcinoma In Situ | GUERBET LLC | $124,781 | 0 |
| Qualitative and Quantitative Performance of Gadopiclenol in Cardiovascular Magnetic Resonance Imaging | GUERBET LLC | $39,395 | 0 |
| Efficacy and Safety of Gadopiclenol for Central Nervous System (CNS) Magnetic Resonance Imaging (MRI) (PICTURE) | GUERBET LLC | $28,200 | 0 |
Top Doctors Receiving Payments for ELUCIREM — Page 3
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Diagnostic Radiology | St Louis Park, MN | $1,500 | 1 |
| , M.D,PHD | Diagnostic Radiology | Atlanta, GA | $1,500 | 1 |
| , M.D | Cardiovascular Disease | Baltimore, MD | $1,458 | 5 |
| , MD | Diagnostic Radiology | Bronx, NY | $1,316 | 4 |
| Gaurav Khatri | Diagnostic Radiology | Dallas, TX | $1,223 | 2 |
| , M.D | Neuroradiology | New York, NY | $1,137 | 3 |
| , MD | Family Medicine | Phoenix, AZ | $1,000 | 1 |
| , M.D | Diagnostic Radiology | New York, NY | $784.00 | 2 |
| , MD | Diagnostic Radiology | New York, NY | $784.00 | 2 |
| , M.D | Diagnostic Radiology | San Diego, CA | $750.00 | 1 |
| , M.D | Diagnostic Radiology | Seattle, WA | $750.00 | 1 |
| , MD | Body Imaging | San Diego, CA | $231.98 | 1 |
| , M.D | Diagnostic Radiology | Pensacola, FL | $179.43 | 2 |
Ad
Manufacturing Companies
- GUERBET LLC $864,951
Product Information
- Type Drug
- Total Payments $864,951
- Total Doctors 62
- Transactions 341
About ELUCIREM
ELUCIREM is a drug associated with $864,951 in payments to 62 healthcare providers, recorded across 341 transactions in the CMS Open Payments database. The primary manufacturer is GUERBET LLC.
Payment data is available from 2022 to 2024. In 2024, $678,696 was paid across 184 transactions to 35 doctors.
The most common payment nature for ELUCIREM is "Unspecified" ($472,608, 54.6% of total).
ELUCIREM is associated with 5 research studies, including "MR Image Quality and Liver Lesion Detection with Gadopiclenol: Comparison with Gadoxetate Disodium" ($146,882).